Assignee
SPRUCE BIOSCIENCES INC
US·13 granted patents·12 pending applications·78 citations·filing 2018–2025
Top patents by PatentIndex Score
25 records- 0195US11351177B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2021·Granted Jun 7, 2022·7 cites·21 claims
- 0295US11344557B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2020·Granted May 31, 2022·7 cites·27 claims
- 0395US11311549B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2021·Granted Apr 26, 2022·7 cites·21 claims
- 0495US11007201B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2020·Granted May 18, 2021·14 cites·19 claims
- 0594US12115166B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2023·Granted Oct 15, 2024·4 cites·21 claims
- 0694US11304950B2Methods for treating testicular and ovarian adrenal rest tumorsSPRUCE BIOSCIENCES INC·Filed 2020·Granted Apr 19, 2022·8 cites·19 claims
- 0794US10849908B2Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2019·Granted Dec 1, 2020·16 cites·25 claims
- 0893US11858932B2Methods and compositions for treating polycystic ovary syndromeSPRUCE BIOSCIENCES INC·Filed 2023·Granted Jan 2, 2024·6 cites·21 claims
- 0993US11708372B2Crystalline composition of tildacerfont and methods of use and preparation thereofSPRUCE BIOSCIENCES INC·Filed 2022·Granted Jul 25, 2023·6 cites·12 claims
- 1091US12098152B2Methods and compositions for treating polycystic ovary syndromeSPRUCE BIOSCIENCES INC·Filed 2023·Granted Sep 24, 2024·3 cites·21 claims
- 1184US2025064812A1Methods for treating testicular and ovarian adrenal rest tumorsSPRUCE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1281US2023321112A1Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1378US2022143037A1Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1476US12576084B2Methods for treating testicular and ovarian adrenal rest tumorsSPRUCE BIOSCIENCES INC·Filed 2025·Granted Mar 17, 2026·0 cites·19 claims
- 1576US12569491B2Methods for treating testicular and ovarian adrenal rest tumorsSPRUCE BIOSCIENCES INC·Filed 2025·Granted Mar 10, 2026·0 cites·19 claims
- 1676US12569490B2Methods for treating testicular and ovarian adrenal rest tumorsSPRUCE BIOSCIENCES INC·Filed 2025·Granted Mar 10, 2026·0 cites·21 claims
- 1776US2022211711A1Methods for treating testicular and ovarian adrenal rest tumorsSPRUCE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1875US2025206733A1Methods and compositions for treating polycystic ovary syndromeSPRUCE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1972US2024261300A1Methods of treating congenital adrenal hyperplasiaSPRUCE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2068US2024043432A1Crystalline composition of tildacerfont and methods of use and preparation thereofSPRUCE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2166US2021361664A1Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2264US2022133742A1Methods of treating congenital adrenal hyperplasiaSPRUCE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2363US2024293421A1Crystalline composition of tildacerfont and methods of use and preparation thereofSPRUCE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2448US2020255436A1Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2540US2021137935A1Corticotropin releasing factor receptor antagonistsSPRUCE BIOSCIENCES INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SPRUCE BIOSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →